USE OF BOTULINUM TOXIN TYPE A IN THE TREATMENT OF SPASTICITY IN CHILDREN WITH CEREBRAL PALSY

Cerebral palsy has an incidence of about 1-2 per 1000 live births, and in spite of the progress of neonatal medicine, it seems that the incidence will not subside in the near future. The most important characteristic of cerebral palsy is movement abnormality: spasticity, chorea, athetosis, ataxia, d...

Full description

Bibliographic Details
Main Authors: Ljiljana Lazić, Hristina Čolović, Olga Marinković, Marija Spalević, Anita Stanković, Dragan Zlatanović
Format: Article
Language:English
Published: University in Nis, Faculty of Medicine 2011-06-01
Series:Acta Medica Medianae
Subjects:
Online Access:http://publisher.medfak.ni.ac.rs/2011-html/2-broj/952-Ljiljana%20Lazic-USE%20OF%20BOTULINUM%20TOXIN.pdf